Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: A comparison with fluticasone propionate

Journal of Asthma

Volumn 44, Issue 6, 2007, Pages 437-441

  Rojas, Ramon A ^a   Paluga, Igor ^b   Goldfrad, Caroline H ^c   Duggan, Marie T ^c   Barnes, Neil ^d  

^a Centro Privado de Cardiolia   (Argentina)

^b Department of Clinical Immunology and Allergology ^*  (Slovakia)

^c GLAXOSMITHKLINE   (United Kingdom)

^d LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Asthma; Clinical trial; Flixotide; Initial maintenance treatment; Seretide

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; ASTHMA; BRONCHITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE FREE INTERVAL; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPHONIA; EXCITABILITY; FEMALE; HOARSENESS; HUMAN; INCIDENCE; INHALER; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; RISK; SIDE EFFECT; TACHYCARDIA; THRUSH; TREMOR;

ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; RESPIRATORY FUNCTION TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547207013     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701421930     Document Type: Article

References (10)

1. Global Initiative for Asthma (GINA). Global Strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute; 2002. Publication 02-3659.
2. British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58 (suppl 1): i1-i94.
3. Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M. Initial treatment of symptomatic mild to moderate bronchial asthma with salmeterol/fluticasone propionate (50/250 mcg) combination product (SAS40023). Eur J Med Res 2002; 7:1-7.
4. Quanjer PH, Tammeling GJ, Cotes JS, Pederson OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardisation of Lung Function Tests. European Community for Coal and Steel (ECCS). Official Statement of the European Respiratory Society. Eur Resp J Supp 1993; 16:5-40.
5. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and Standards. Philadelphia: WB Saunders, 1971.
6. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: Wiley, 1973.
7. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute; 1997. Publication 97-4051.
8. Rabe KF, Vermeire M, Soriano J, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807.
9. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Ann Allergy Asthma Immunol 1999; 82:257-265.
10. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836-844.